# A Comparison of Risperidone With Haloperidol in Patients With Schizophrenia and Schizoaffective Disorder

> **NCT00253110** · PHASE4 · COMPLETED · sponsor: **Janssen, LP** · enrollment: 396 (actual)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder

## Interventions

- **DRUG:** risperidone
- **DRUG:** haloperidol

## Key facts

- **NCT ID:** NCT00253110
- **Lead sponsor:** Janssen, LP
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-05
- **Primary completion:** —
- **Final completion:** 1998-09
- **Target enrollment:** 396 (ACTUAL)
- **Last updated:** 2012-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00253110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00253110, "A Comparison of Risperidone With Haloperidol in Patients With Schizophrenia and Schizoaffective Disorder". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00253110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*